Glycopyrrolate Injection
Product Images NDC 51662-1484

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 51662-1484). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Clinical (Clinical Pharma)

FDA Label Image

Serialized Labeling (Serialized Vial Labeling)

This is a label of a medication containing 4mg/20mL of a drug that should not be used for anything but intramuscular or intravenous administration. The medication comes in a 20 mL multiple dose vial and contains Benzyl Alcohol, and the manufacturer's package insert should be consulted. The distributed company is HF Acquisition Co., LLC located in Mukilteo, WA 98275. NDC 0143-9679-01 is the product code.*

FDA Label Image

Structure (Structure)

FDA Label Image

Vial Label (Vial Labeling)

Beonly Glycopyrrolate Injection, USP, is a medication used in newborns as indicated in the package. The injection has a concentration of 4 mg/ml and is administered through the intramuscular or intravenous route. This injection is preserved with benzyl alcohol, and its pH is adjusted with hydrochloric acid and/or sodium hydroxide when necessary. The usual dosage is available in the package insert. The drug comes in 20ml vials and should be stored at controlled room temperature. The manufacturer is WEST-WARD, located in Eatonton, NJ, USA. Lot and expiration information is available on the package.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.